玩股撇步(動畫小學堂)  

  • 營業利益和稅後淨利成長率大於營收成長率, 通常代表公司在成長, 如果是漲很多的股票, 發現沒有這個現象就要留意了
  • 營收到某個數字後, 營業利益產生不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)220.00.04.1925.0734.735.0563.4344.2913.3945.5420.746.4429.8424.0874.2043.491.781.2946.5937.230.9325.6834.7817.18-9.534.2514.47-3.68.9617.0225.0444.77
23Q3 (19)220.00.03.3525.039.583.0926.1228.229.2057.2615.144.964.216.4351.715.47-0.920.8835.3825.710.7423.3339.6218.9926.5216.015.0119.9820.085.464.640.99
23Q2 (18)220.046.672.68-15.72-44.862.45-24.15-13.125.8583.96-28.44.766.733.9349.03-8.53-5.530.65-27.78-17.720.6-15.49-18.9215.01-25.55-24.8412.51-20.92-22.39-3.67-6.74-15.93
23Q1 (17)220.046.673.182.25-3.933.23-7.7157.563.18-71.33-3.934.46-14.073.2453.60-26.4713.320.9-4.2666.670.712.942.020.1622.3347.1515.8219.1335.683.8815.9118.76
22Q4 (16)220.046.673.1129.58-30.893.5045.2311.4611.0938.8-32.875.1921.835.772.9039.6832.810.9434.2910.590.6930.191.4716.480.67-3.7413.286.24-4.257.42-10.5215.34
22Q3 (15)2246.6746.672.40-50.62-45.332.41-14.54-19.677.99-2.2-33.534.26-6.991.6752.190.56-0.80.7-11.39-15.660.53-28.38-19.716.37-18.03-16.4412.50-22.46-21.73-0.49-1.8911.51
22Q2 (14)150.00.04.8646.838.02.8237.56-11.328.17146.837.084.586.0215.0851.909.73-5.150.7946.3-9.20.7448.08.8219.9745.77-6.9416.1238.25-6.44-3.0010.191.43
22Q1 (13)150.00.03.31-26.445.752.05-34.71-4.213.31-79.965.754.32-12.0226.3247.30-13.83-8.670.54-36.47-10.00.5-26.476.3813.70-19.98-21.8511.66-15.93-16.892.58-11.96-15.02
21Q4 (12)150.00.04.502.5114.213.144.6717.1616.5237.4433.984.9117.1855.8754.894.33-2.490.852.4111.840.683.0315.2517.12-12.61-28.8413.87-13.15-27.2711.230.03-0.50
21Q3 (11)150.00.04.39-2.4474.93.00-5.6669.4912.0257.5443.14.195.2873.8652.61-3.86-3.110.83-4.650.910.66-2.9473.6819.59-8.71-12.1915.97-7.31-0.3110.8320.6721.47
21Q2 (10)150.00.04.5043.7749.53.1848.655.127.63143.7729.543.9816.3765.8354.725.662.360.8745.050.00.6844.6851.1121.4622.42-11.2917.2322.81-10.6312.4711.6114.23
21Q1 (9)150.00.03.13-20.568.682.14-20.159.743.13-74.618.683.428.5746.7851.79-7.990.040.6-21.057.140.47-20.349.317.53-27.14-27.1714.03-26.43-25.9619.6418.2015.63
20Q4 (8)150.07.143.9456.9750.382.6851.4151.4112.3346.79-20.193.1530.7129.6356.293.664.90.7638.1831.030.5955.2659.4624.067.843.019.0719.0423.1915.5720.1818.88
20Q3 (7)150.07.142.51-16.61-33.771.77-13.66-26.568.4042.61-34.632.410.42-8.7154.301.570.460.55-5.17-20.290.38-15.56-28.322.31-7.77-14.2916.02-16.91-21.851.71-6.05-4.27
20Q2 (6)150.07.143.014.51-38.452.055.13-31.675.89104.51-34.992.43.0-14.2953.463.26-2.180.583.57-27.50.454.65-33.8224.190.5-17.7819.281.74-22.1-0.567.217.65
20Q1 (5)157.147.142.889.92-30.941.9510.17-26.142.88-81.36-30.942.33-4.12-6.851.77-3.52-4.970.56-3.45-20.00.4316.22-25.8624.073.04-13.6718.9522.42-20.45--0.00
19Q4 (4)140.00.02.62-30.870.01.77-26.560.015.4520.230.02.43-7.950.053.66-0.720.00.58-15.940.00.37-30.190.023.36-10.260.015.48-24.490.0--0.00
19Q3 (3)140.00.03.79-22.490.02.41-19.670.012.8541.830.02.64-5.710.054.05-1.10.00.69-13.750.00.53-22.060.026.03-11.520.020.50-17.170.0--0.00
19Q2 (2)140.00.04.8917.270.03.0013.640.09.06117.270.02.812.00.054.650.310.00.814.290.00.6817.240.029.425.520.024.753.90.0--0.00
19Q1 (1)140.00.04.170.00.02.640.00.04.170.00.02.50.00.054.480.00.00.70.00.00.580.00.027.880.00.023.820.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/21.62-7.0411.143.3615.645.14N/A-
2024/11.74-2.2620.171.7420.176.38N/A-
2023/121.78-37.5316.720.7413.046.530.4-
2023/112.8550.3731.618.9612.716.410.41-
2023/101.914.0329.5716.119.915.320.5-
2023/91.66-5.6820.5914.217.734.960.56-
2023/81.7615.1523.3212.556.234.870.57-
2023/71.53-2.655.4710.793.884.790.58-
2023/61.57-6.43-0.99.253.624.760.44-
2023/51.6811.824.927.684.64.770.44-
2023/41.5-5.326.146.04.514.550.46-
2023/31.599.0511.214.493.974.490.39-
2023/21.460.516.552.910.44.430.4-
2023/11.45-5.09-5.11.45-5.15.140.34-
2022/121.53-29.55-7.318.3511.425.160.3-
2022/112.1748.0622.3316.8213.55.010.31-
2022/101.466.120.214.6612.34.270.36-
2022/91.38-3.54-0.0213.1913.824.260.38-
2022/81.43-1.510.8911.8115.694.470.37-
2022/71.45-8.533.9610.3818.084.640.35-
2022/61.59-0.9410.968.9320.754.610.27-
2022/51.613.1216.117.3423.14.450.28-
2022/41.42-0.821.585.7425.24.210.3-
2022/31.434.4720.184.3226.434.320.22-
2022/21.37-10.4824.092.8929.774.540.2-
2022/11.53-7.2835.311.5335.314.950.19-
2021/121.65-7.0335.6916.4760.064.880.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有累計虧損,長期來看需謹慎觀察
2021/111.7721.2753.3714.8263.324.610.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有累計虧損,長期來看需謹慎觀察
2021/101.465.8887.5313.0564.774.260.11因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/91.38-2.6567.0311.5962.294.190.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/81.421.4881.0910.2161.674.250.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/71.4-2.3874.188.7958.924.210.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/61.433.6572.557.456.343.980.1因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/51.3818.4668.725.9652.893.730.11因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/41.17-1.9455.774.5848.693.460.12因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚有大額累計虧損,長期來看需謹慎觀察
2021/31.197.8753.063.4246.423.420.07因直播成長與大研生醫熱銷,惟大研採用國際頂級臨床醫學實證原料與研發專利配方成本頗高,尚在虧損中,長期來看需謹慎觀察。
2021/21.1-2.3840.22.2343.113.440.07-
2021/11.13-7.0246.071.1346.073.50.07-
2020/121.215.0735.4610.29-0.773.150.03-
2020/111.1648.2858.699.08-4.22.760.04因1111單身節與購物節檔期,使直播、交友與保健品收入都有所增加,有可能為短期效應,長期來看還需謹慎觀察。
2020/100.78-5.68-3.527.92-9.432.390.04-
2020/90.835.53-3.617.14-10.042.410.01-
2020/80.78-2.39-12.986.31-10.812.410.01-
2020/70.8-3.29-8.775.53-10.52.450.01-
2020/60.831.35-13.544.73-10.782.40.02-
2020/50.829.36-11.13.9-10.182.340.02-
2020/40.75-3.64-18.623.08-9.932.310.02-
2020/30.78-1.18-16.472.33-6.742.330.04-
2020/20.791.69-1.51.56-0.992.450.04-
2020/10.77-13.77-0.460.77-0.462.40.04-
2019/120.923.09-10.3910.3724.942.430.04-
2019/110.73-9.84-11.539.4729.782.390.04-
2019/100.81-5.77-3.448.7535.032.560.04-
2019/90.86-4.7319.277.9440.732.640.04-
2019/80.92.3330.317.0843.872.740.04-
2019/70.88-8.3450.096.1846.082.760.04因「愛情公寓iPair」交友APP新推出之「直播聊天功能」大受好評,使各主播收禮分潤收入屢創新高,故本月營收較去年同期大幅成長
2019/60.964.2139.465.345.432.80.04-
2019/50.920.1138.464.3446.822.770.04-
2019/40.92-1.1158.693.4249.250.0N/A因「愛情公寓iPair」交友APP新推出之「直播聊天功能」大受好評,使各主播收禮分潤收入屢創新高,故本月營收較去年同期大幅成長
2019/30.9316.5334.172.546.050.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)220.013.3720.8913.8228.820.6212.3758.522.973.7225.683.6619.612.9821.14
2022 (9)2246.6711.06-32.5610.73-6.718.3511.2156.835.972.96-6.033.06-1.922.46-1.6
2021 (8)150.016.4034.6511.5036.0916.560.3553.63-0.943.1528.573.1227.872.535.14
2020 (7)157.1412.18-19.68.45-13.9510.29-0.7754.14-0.152.45-11.552.44-12.231.85-14.75
2019 (6)140.015.1515.659.8218.7410.3724.9454.221.782.7736.452.7833.012.1715.43
2018 (5)140.013.1008.2708.370.4353.27-5.452.0302.0901.880
2017 (4)147.69-0.640-0.1404.8746.6956.34-18.76-0.030-0.090-0.090
2016 (3)130.0-6.310-3.8203.3236.6369.35-12.9-0.840-0.850-0.850
2015 (2)130.0-5.680-3.2702.43-7.679.62-4.43-0.720-0.710-0.710
2014 (1)138.331.08-83.120.64-81.232.63-14.0583.3100.17-81.520.17-82.470.14-82.5

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。